In summary, our study has demonstrated dysregulation, prognosis, and potential function of m6A gene in NPC, and verified the low expression and clinical significance of METTL3 in NPC using immunohistochemical techniques. The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.